Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 2
1988 pubmed 19 citations

A cellular basis for functionally releasable pools in somatotropes.

Chao. C C CC; Hoeffler. J P JP; Frawley. L S LS

Key Findings

  • GHRP-6 stimulates GH release in only ~50% of somatotropes, whereas GRF stimulates nearly all cells.
  • GHRP-6 causes rapid release of a small, pre‑existing GH pool, leading to a quick but modest increase.
  • GRF accesses a larger GH pool that results in greater overall hormone output over time.

Practical Outcomes

  • When using GHRP-6 for GH boosting, expect a fast but relatively small GH surge. To achieve larger or longer‑lasting GH elevations, consider pairing GHRP-6 with other secretagogues like GRF (e.g., CJC‑1295) or using higher‑frequency dosing. The findings suggest that GHRP-6 alone may not maximize total GH output.

Summary

The study shows that the peptide GHRP-6 triggers a fast release of growth hormone, but only from about half of the pituitary cells that can make GH. In contrast, the natural hormone‑releasing factor (GRF) activates almost all GH‑producing cells and taps a larger hormone reserve. This means GHRP-6 gives a quick, limited GH spike, while GRF can produce a bigger, more sustained release.

Abstract

In an attempt to define the cellular basis for the phenomenon of releasable pools, we compared the effects of two growth hormone (GH)-releasing peptides which differentially influence the dynamics of GH release. Monodispersed anterior pituitary cells from neonatal male rats were subjected to reverse hemolytic plaque assays for GH in the presence or absence of GH-releasing peptide (GHRP-6, an enkephalin-like hexapeptide) and rat GH-releasing factor (GRF). GRF increased the rate of plaque formation (an index of the rate of hormone release) from almost all somatotropes, whereas GHRP-6 influenced only half of these cells. Analysis of plaque sizes (which provides a relative index of the cumulative amount of hormone released per cell) revealed that GRF produced a bimodal frequency distribution of plaque sizes, demonstrating that some somatotropes released more hormone than others after treatment with a maximal dose of this secretagogue. This pattern contrasted with those of untreated and GHRP-6 treated somatotropes which each produced unimodal frequency distributions that were skewed to the left (toward smaller plaques) and were virtually superimposable at the end of a 4 h incubation. However, GHRP-6 greatly accelerated the rate at which the final size distribution pattern was attained. Taken together, these results suggest that GHRP-6 causes the immediate release of a limited pool of GH which is present only in a discrete subpopulation of somatotropes that respond to GRF. This pool may be identical to that which is released over a more prolonged period under basal conditions. Moreover, GRF appears to access a more substantial pool of hormone which is not released by GHRP-6. This pool is present in a small minority of somatotropes but probably accounts for a larger portion of the GH released by pituitaries stimulated with GRF.

Study Information

Provider

pubmed

Year

1988

DOI

10.1016/0024-3205(88)90462-6

Citations

19

References

18